rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
1998-1-12
|
pubmed:abstractText |
To find a means of achieving operability very quickly without the additional discomfort of prolonging systemic chemotherapy. To improve the patient's quality of life by obtaining quick tumor reduction and decreasing systemic toxicity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0026-4733
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1077-82
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9401355-Adult,
pubmed-meshheading:9401355-Aged,
pubmed-meshheading:9401355-Antibiotics, Antineoplastic,
pubmed-meshheading:9401355-Antimetabolites, Antineoplastic,
pubmed-meshheading:9401355-Breast Neoplasms,
pubmed-meshheading:9401355-Breast Neoplasms, Male,
pubmed-meshheading:9401355-Chemotherapy, Adjuvant,
pubmed-meshheading:9401355-Epirubicin,
pubmed-meshheading:9401355-Female,
pubmed-meshheading:9401355-Fluorouracil,
pubmed-meshheading:9401355-Follow-Up Studies,
pubmed-meshheading:9401355-Humans,
pubmed-meshheading:9401355-Infusions, Intra-Arterial,
pubmed-meshheading:9401355-Male,
pubmed-meshheading:9401355-Middle Aged,
pubmed-meshheading:9401355-Mitomycins,
pubmed-meshheading:9401355-Neoplasm Recurrence, Local,
pubmed-meshheading:9401355-Time Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
Four years experience of primary intra-arterial chemotherapy (PIAC) for locally advanced and recurrent breast cancer.
|
pubmed:affiliation |
Divisione di Oncologia Medica, Azienda Ospedaliera C. Poma, Mantova.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|